EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62020TA0636
Case T-636/20: Judgment of the General Court of 6 October 2021 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VOLUMA) (EU trade mark — Invalidity proceedings — EU word mark JUVÉDERM VOLUMA — Late payment of the appeal fee — Inadmissibility of the appeal before the Board of Appeal — Article 101(4) of Regulation (EU) 2017/1001 — Article 106(1)(b) of Regulation 2017/1001 — Restitutio in integrum)
Kawża T-636/20: Sentenza tal-Qorti Ġenerali tas-6 ta’ Ottubru 2021 – Dermavita Company vs EUIPO – Allergan Holdings France (JUVÉDERM VOLUMA) (Trade mark tal-Unjoni Ewropea – Proċedimenti ta’ invalidità – Trade mark verbali tal-Unjoni Ewropea JUVÉDERM VOLUMA – Ħlas tardiv tal-ispejjeż tar-rikors – Inammissibbiltà tar-rikors quddiem il-Bord tal-Appell – Artikolu 101(4) tar-Regolament (UE) 2017/1001 – Artikolu 106(1)(b) tar-Regolament 2017/1001 – Restitutio in integrum)
Kawża T-636/20: Sentenza tal-Qorti Ġenerali tas-6 ta’ Ottubru 2021 – Dermavita Company vs EUIPO – Allergan Holdings France (JUVÉDERM VOLUMA) (Trade mark tal-Unjoni Ewropea – Proċedimenti ta’ invalidità – Trade mark verbali tal-Unjoni Ewropea JUVÉDERM VOLUMA – Ħlas tardiv tal-ispejjeż tar-rikors – Inammissibbiltà tar-rikors quddiem il-Bord tal-Appell – Artikolu 101(4) tar-Regolament (UE) 2017/1001 – Artikolu 106(1)(b) tar-Regolament 2017/1001 – Restitutio in integrum)
ĠU C 481, 29.11.2021, p. 27–28
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
29.11.2021 |
MT |
Il-Ġurnal Uffiċjali tal-Unjoni Ewropea |
C 481/27 |
Sentenza tal-Qorti Ġenerali tas-6 ta’ Ottubru 2021 – Dermavita Company vs EUIPO – Allergan Holdings France (JUVÉDERM VOLUMA)
(Kawża T-636/20) (1)
(Trade mark tal-Unjoni Ewropea - Proċedimenti ta’ invalidità - Trade mark verbali tal-Unjoni Ewropea JUVÉDERM VOLUMA - Ħlas tardiv tal-ispejjeż tar-rikors - Inammissibbiltà tar-rikors quddiem il-Bord tal-Appell - Artikolu 101(4) tar-Regolament (UE) 2017/1001 - Artikolu 106(1)(b) tar-Regolament 2017/1001 - Restitutio in integrum)
(2021/C 481/39)
Lingwa tal-kawża: l-Ingliż
Partijiet
Rikorrent: Dermavita Company S.a.r.l. (Bejrut, il-Libanu) (rappreżentant: D. Todorov, avukat)
Konvenut: L-Uffiċċju tal-Proprjetà Intellettwali tal-Unjoni Ewropea (rappreżentanti: E. Markakis u V. Ruzek, aġenti)
Parti oħra fil-proċedimenti quddiem il-Bord tal-Appell tal-EUIPO: Allergan Holdings France SAS (Courbevoie, Franza)
Suġġett
Rikors ippreżentat kontra d-deċiżjoni tar-Raba’ Bord tal-Appell tal-EUIPO tal-24 ta’ Awwissu 2020 (Każ R 1016/2020-4), dwar proċedimenti ta’ invalidità bejn Dermavita Company u Allergan Holdings France.
Dispożittiv
1) |
Ir-rikors huwa miċħud. |
2) |
Dermavita Company S.a.r.l. hija kkundannata għall-ispejjeż. |